Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 37.60
-1.55 (-3.96%)
Apr 20, 2026, 1:24 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.56 billion as of April 20, 2026. Its market cap has decreased by -32.59% in one year.
Market Cap
1.56B
Enterprise Value
1.60B
Revenue
698.11M
Ranking
n/a
PE Ratio
44.12
Stock Price
37.60
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.56B, a decrease of -7.42%. That is a compound annual growth rate of -1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.56B | -37.86% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| A Plus Biotechnology | 2.49B |
| Applied BioCode | 2.34B |
| Wellell | 2.27B |
| OK Biotech | 1.89B |
| Taiwan Biomaterial | 1.67B |
| Cowealth Medical Holding | 1.48B |
| Bioptik Technology Incorporation | 1.45B |
| PlexBio | 1.35B |